Introduction
Infections acquired during the use of health-care services are significant public health problems both for the health-care delivery system and the patient. It has been reported that an estimated 220,000 nosocomial infections are acquired in health-care facilities and 8000 deaths attributable to these infections occur annually in Canada [1] . The most common nosocomial infections are surgical wounds, blood stream, and urinary tract infections [2, 3] . Taylor et al. reported that the relative risk for bloodstream infection (BSI) was 2.5 with arteriovenous graft access, 15.5 with cuffed and tunnelled central venous catheter (CVC) access, and 22.5 with uncuffed CVC access [4] .
Nosocomial BSIs result in dramatic increases in economic cost. In the United States in 2000, approximately 240,000 dialysis patients were treated at 3700 outpatient facilities [5] . The length of hospital stay was extended by 1 to 4 weeks at a cost of up to $40,000 (US dollars) per survivor [6] [7] [8] [9] . The US Centers for Disease Control and Prevention (US CDC)estimated that the excess costs associated with nosocomial infections in US hospitals were $4.5 billion in 1992 [10] . In Canada, there are no detailed reports on excess costs associated with nosocomial infections, including BSIs.
The purpose of this study was to determine the cost of nosocomial BSIs among hemodialysis patients in Canada in 2004. We also estimated the cost of an infection control program a middlesized hospital in Canada in 2004 with the assumption that the outpatient hemodialysis centre is run out of the hospital. Finally, we conducted cost-benefit analyses of establishing and running hospital-based infection control programs in Canada.
Methods

Incidence Rate of BSI in Canada
We have used the data from a prospective surveillance study by Taylor et al. [11] . During the 6-month follow-up period between 1 December 1998 and 31 May 1999, there were 184 BSIs which occurred in 133,158 dialysis procedures with an incidence rate of 1.4 cases per 1000 procedures in 11 hemodialysis centres across Canada.
Estimation of Average Treatment Cost per Stay (Unit Cost)
According to the surveys of BSIs, out of the 6697 patients in 59 hospitals in the United States, the inpatients and the outpatients accounted for 60% and 40% of total BSI cases respectively [12] . We used the cost of acute care hospital stays by medical condition in Canada 2004 to 2005 to estimate the cost of BSI per stay [13] . The cost attributable to the treatment of one case of BSI among all genders in 2004 was CAD$19,418 per stay. The treatment costs for the outpatients with BSIs are significantly lower. There was no valid estimate from previous studies. We assumed that the treatment costs of the outpatients with BSIs were CAD$8,000 to CAD$12,000. We conducted a sensitivity analysis for the costbenefit of different scenarios.
Total Hemodialysis Patients in Canada in 2004
According to the Canadian Institute for Health Information's statistics [14] , there were a total of 15,278 hemodialysis patients and 1,802,922 hemodialysis procedures in Canada in 2004.
Investment Cost of Establishing and Maintaining an Infection Control Program in a Hospital
In 1975, the US CDC estimated the cost of an infection control program that was implemented in a 250-bed hospital. These estimates were subsequently revised in 1979, and further adjusted to 1985 prices [15] . Personnel resources for a hospital infection control program included a hospital epidemiologist, an infection control practitioner (nurse), and one secretary and computer support personnel. There was also nonpersonnel support such as office support, computing support, audiovisual support, microbiology laboratory support, pathology services, and reference laboratory testing. We assumed that the infection control team took 10% of their time investigating BSI [16] . The cost of establishing and maintaining an infection control program in 1985 US$ was estimated to be US$60,000 [15] . This estimate (US$60,000) included the costs of employing an infection control nurse, a part-time physician consult, part-time clerical support, and the cost of consumables and overheads. So far, there is no accurate estimate of annual cost for establishing and maintaining an infection control program in a hospital in Canada. We applied the unit cost in US$ as a surrogate indicator for our cost analysis. According to the Bank of Canada's inflation rate statistics, there was an average annual inflation rate of 2. 
Estimate of the Gross Benefits of Prevention
In the early 1980s, an effective infection control programdefined by an appropriately trained clinical leader, one infection control practitioner for 250 beds and a nosocomial surveillance program-decreased the prevalence of endemic nosocomial infection in acute care facilities by 30% to 50% [17] . Since most of hemodialysis patients were outpatients, we assumed that the BSI prevalence could be prevented by the range of 10% to 30%. We applied the 10% to 30% reduction in BSIs to calculate the gross benefits of infection control programs for the health sectors in Canada.
Results
Average Yearly Cost Attributable to Nosocomial BSIs in Canada in 2004
There were a total of 1,802,922 hemodialysis procedures in Canada in 2004. Since the incidence rate was 1.4 cases per 1000 hemodialysis procedures, a total of 2524 BSIs cases were estimated by multiplying 1,802,922 hemodialysis procedures with 1.4 cases/1000 procedures.
Total annual cost to treat 2524 BSIs cases was estimated to be 49.01 million by multiplying 2524 BSIs cases by CAD$19,418 per stay for one BSI case. Table 1 illustrates the potential benefits of implementing infection control programs in all hemodialysis units in Canada in 2004 by different scenarios of avoidable BSI prevalence rate. For example, if the available BSI rate was decreased by 15%, the potential benefits (cost-savings) for implementing infection control programs was estimated to be CAD$7.35 million per year by multiplying CAD$49.01 million by 15%.
Cost for Investment in Prevention Measures and Human Resources
Suppose that one infection control team is responsible for 250 hemodialysis patients; a total of 15,278 patients would need about 61 infection control programs across Canada in 2004.
Total running costs for implementing infection control programs in 2004 was estimated to be CAD$8.15 million by multiplying 61 infection control programs by CAD$133,633/ program.
Cost-benefit Analysis
There are close correlations between the ratios of benefit/cost and avoidable BSI rates. Figure 1 depicts the sensitivity analysis of the ratios of benefit/cost in different scenarios of avoidable BSI rates. If the avoidable BSI rate maintained around 17%, the ratio of benefitcost would reach to 1:1. If the avoidable BSI rate increased to 30%, the ratio of benefit-cost would reach to 1.80:1.
Sensitivity Analysis for Outpatients
In the previous calculations, we assumed that the treatment costs of the outpatients were the same as the hospitalized patients. In reality, hemodialysis outpatients have lower treatment costs for BSIs. Table 2 illustrates the sensitivity analysis of cost-benefit ratios by infection control programs among inpatients and outpatients in Canada. When the outpatients treatment costs are maintained at CAD$12,000 per BSIs and the inpatients costs are maintained at CAD$19,418, and the infection control program can prevent the 20% of the total of BSIs, the benefit/cost ratio would be 1.01:1.
Discussion
In Canada, the number of hemodialysis patients doubled from 7098 in 1996 to 15,938 in 2005 because of the ageing community, diabetes, other underlying causes, and the increased 
